Enzychem Lifesciences Corporation (KOSDAQ:183490)

Enzychem Lifesciences Revenue

Enzychem Lifesciences had revenue of 23.54B KRW in the quarter ending June 30, 2026, with 43.55% growth. This brings the company's total for the last twelve months to 69.00B, down -5.10% year-over-year. In the year 2025, Enzychem Lifesciences had annual revenue of 67.75B, down -12.44%. That makes Enzychem Lifesciences the 27,745th largest company in the world by revenue and 1,681st in South Korea.

• Revenue (ttm): 69.00B
• Revenue Growth: -5.10%
• P/S Ratio: 1.11
• Revenue / Employee: 741.96M
• Employees: 93
• Market Cap: 76.86B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Bio-oil Division 44.85B 66.2%
• Active Pharmaceutical Ingredients (API) Division 22.34B 33.0%
• Health Functional Food Division 563.06M 0.8%

By Geography

Chart

• South Korea 63.64B 93.9%
• Overseas 4.11B 6.1%

Fiscal year ended Dec 31, 2025 See the full Enzychem Lifesciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	67.75B	-9.63B	-12.44%
Dec 31, 2024	77.38B	1.34B	1.76%
Dec 31, 2023	76.04B	49.40B	185.46%
Dec 31, 2022	26.64B	3.66B	15.94%
Dec 31, 2021	22.98B	-2.84B	-11.01%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error